טופמקס ספרינקל 25 מ"ג כמוסות

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

TOPIRAMATE 25 MG

Commercializzato da:

J-C HEALTH CARE LTD

Codice ATC:

N03AX11

Forma farmaceutica:

CAPSULES

Via di somministrazione:

PER OS

Prodotto da:

JANSSEN CILAG S.P.A., ITALY

Gruppo terapeutico:

TOPIRAMATE

Indicazioni terapeutiche:

In adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. In adjunctive therapy of seizures with Lennox-Gastaut syndrome in adults and children. Topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. Topamax is indicated in adults for the prevention of migraines. The use of Topamax in the acute treatment of migraine has not been studied.

Data dell'autorizzazione:

2012-02-01